Who owns Monopar Therapeutics Inc?
- Ticker: MNPR
- CUSIP Number: 61023l108
Tip: Access positions for across all investors
Analyze quarterly positions in Monopar Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Monopar Therapeutics stock
Who bought or sold Monopar Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Millennium Management | 192k | $131k | 556% | Mar 2024 |
|
| Vanguard Group | 45k | $31k | 0% | Mar 2024 |
|
| Geode Capital Management | 41k | $28k | 0% | Mar 2024 |
|
| Hrt Financial | 32k | $21k | 100% | Mar 2024 |
|
| Gerber | 28k | $19k | 0% | Mar 2024 |
|
| Virtu Financial | 24k | $16k | -12% | Mar 2024 |
|
| Rappaport Reiches Capital Management | 11k | $7.3k | 0% | Mar 2024 |
|
| Tower Research Capital | 7.9k | $5.3k | 111% | Mar 2024 |
|
| FMR | 5.5k | $3.7k | 100% | Mar 2024 |
|
| Goss Wealth Management | 3.0k | $2.0k | 100% | Mar 2024 |
|
| UBS Group | 2.6k | $1.7k | -78% | Mar 2024 |
|
| Wells Fargo & Company | 1.5k | $1.0k | 4054% | Mar 2024 |
|
| Morgan Stanley | 800.00 | $544.960000 | 0% | Mar 2024 |
|
| Bank of America Corporation | 500.00 | $340.000000 | 100% | Mar 2024 |
|
| Royal Bank of Canada | 100.00 | $0 | 100% | Mar 2024 |
|
| Federation des caisses Desjardins du Quebec | 80.00 | $54.000000 | 100% | Mar 2024 |
|
Who sold out of Monopar Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Two Sigma Investments | Dec 2023 | 14k | $4.9k |
| Susquehanna International | Sep 2023 | 11k | $6.0k |